Search research articles
Contact Us
Filters
Showing results (81-90 of 345) with videos related to
Page
of 35
Sort By:
Open Forum Infectious Diseases
|
January 23, 2026
Controlled Human Infection of Healthy Adults With Lyophilized <i>Neisseria lactamica</i> Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and Mali
D F Gbesemete, F Haidara, J R Laver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 11, 2019
Overview and Development of the Child Health and Mortality Prevention Surveillance Determination of Cause of Death (DeCoDe) Process and DeCoDe Diagnosis Standards
Dianna M Blau, J Patrick Caneer, Rebecca P Philipsborn, et al.
Vaccine
|
July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions
Rachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
The Lancet. Infectious Diseases
|
March 23, 2020
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Milagritos D Tapia, Samba O Sow, Khardiata D Mbaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
Milagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
The Pediatric Infectious Disease Journal
|
August 27, 2021
The Etiology of Childhood Pneumonia in Mali: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study
Milagritos D Tapia, Mamadou Sylla, Amanda J Driscoll, et al.
Clinical and Vaccine Immunology : CVI
|
October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
Nature Genetics
|
October 2, 2012
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa
Chinyere K Okoro, Robert A Kingsley, Thomas R Connor, et al.
Vaccine
|
September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers
Abraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Lancet (London, England)
|
August 10, 2010
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
George E Armah, Samba O Sow, Robert F Breiman, et al.
Page
of 35
Search research articles
Search
Showing results (81-90 of 345) with videos related to
Sort By:
Page
of 35
Open Forum Infectious Diseases
|
January 23, 2026
Controlled Human Infection of Healthy Adults With Lyophilized <i>Neisseria lactamica</i> Induces Asymptomatic, Immunogenic Nasopharyngeal Carriage in the United Kingdom and Mali
D F Gbesemete, F Haidara, J R Laver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 11, 2019
Overview and Development of the Child Health and Mortality Prevention Surveillance Determination of Cause of Death (DeCoDe) Process and DeCoDe Diagnosis Standards
Dianna M Blau, J Patrick Caneer, Rebecca P Philipsborn, et al.
Vaccine
|
July 30, 2021
Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions
Rachel S Laufer, Amanda J Driscoll, Ranju Baral, et al.
The Lancet. Infectious Diseases
|
March 23, 2020
Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
Milagritos D Tapia, Samba O Sow, Khardiata D Mbaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 11, 2015
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age
Milagritos D Tapia, Helen Findlow, Olubukola T Idoko, et al.
The Pediatric Infectious Disease Journal
|
August 27, 2021
The Etiology of Childhood Pneumonia in Mali: Findings From the Pneumonia Etiology Research for Child Health (PERCH) Study
Milagritos D Tapia, Mamadou Sylla, Amanda J Driscoll, et al.
Clinical and Vaccine Immunology : CVI
|
October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
Nature Genetics
|
October 2, 2012
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa
Chinyere K Okoro, Robert A Kingsley, Thomas R Connor, et al.
Vaccine
|
September 18, 2025
Immunogenicity and safety of a meningococcal a conjugate vaccine administered with routine EPI vaccines in African infants and toddlers
Abraham Hodgson, Fadima Cheick Haidara, Samba O Sow, et al.
Lancet (London, England)
|
August 10, 2010
Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial
George E Armah, Samba O Sow, Robert F Breiman, et al.
Page
of 35